Abbott (ABT) stock price, revenue, and financials

Abbott market cap is $164.4 b, and annual revenue was $31.90 b in FY 2019

$164.4 B

ABT Mkt cap, 06-Jul-2020

$7.7 B

Abbott Revenue Q1, 2020
Abbott Gross profit (Q1, 2020)4.4 B
Abbott Gross profit margin (Q1, 2020), %57.5%
Abbott Net income (Q1, 2020)564 M
Abbott EBIT (Q1, 2020)758 M
Abbott Cash, 31-Mar-20203.4 B
Abbott EV179.3 B

Abbott Revenue

Abbott revenue was $31.90 b in FY, 2019 which is a 4.3% year over year increase from the previous period.

Embed Graph

Abbott Revenue Breakdown

Embed Graph

Abbott revenue breakdown by business segment: 42.2% from Medical Devices, 16.6% from Diagnostics, 15.5% from Established Pharmaceuticals, 25.5% from Nutritionals and 0.2% from Other

Abbott revenue breakdown by geographic segment: 64.3% from International and 35.7% from United States

Abbott Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

20.9b27.4b30.6b31.9b

Revenue growth, %

2%31%12%4%

Cost of goods sold

9.0b12.3b12.7b13.2b

Gross profit

11.8b15.1b17.9b18.7b

Gross profit Margin, %

57%55%58%59%

R&D expense

1.4b2.2b2.3b2.4b

General and administrative expense

6.7b9.1b9.7b9.8b

Operating expense total

8.6b13.3b14.2b14.1b

Depreciation and amortization

550.0m2.0b2.2b1.9b

EBIT

3.2b1.7b3.7b4.5b

EBIT margin, %

15%6%12%14%

Interest expense

431.0m904.0m826.0m670.0m

Interest income

99.0m124.0m105.0m94.0m

Pre tax profit

1.4b2.2b2.9b4.1b

Income tax expense

350.0m1.9b539.0m390.0m

Net Income

1.4b477.0m2.4b3.7b

Abbott Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

18.6b9.4b3.8b3.9b

Accounts Receivable

3.2b5.2b5.2b5.4b

Prepaid Expenses

1.8b1.7b1.6b

Inventories

2.4b3.6b3.8b4.3b

Current Assets

26.8b20.1b14.6b15.7b

PP&E

5.7b7.6b7.6b8.0b

Goodwill

7.7b24.0b23.3b

Total Assets

52.7b76.3b67.2b67.9b

Accounts Payable

1.2b2.4b3.0b3.3b

Dividends Payable

391.0m489.0m563.0m635.0m

Short-term debt

1.3b714.0m207.0m1.5b

Current Liabilities

6.7b8.9b9.0b10.9b

Long-term debt

20.7b27.2b19.4b16.7b

Total Debt

22.0b27.9b19.6b18.1b

Common Stock

13.0b23.2b23.5b23.9b

Retained Earnings

25.6b24.0b24.6b25.8b

Total Equity

20.7b31.1b30.7b31.3b

Debt to Equity Ratio

1.1 x0.9 x0.6 x

Debt to Assets Ratio

0.4 x0.4 x0.3 x

Financial Leverage

2.5 x2.5 x2.2 x2.2 x

Abbott Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

1.4b477.0m2.4b3.7b

Depreciation and Amortization

1.4b3.0b3.3b3.0b

Accounts Receivable

(177.0m)(207.0m)(190.0m)(275.0m)

Inventories

(98.0m)249.0m(514.0m)(593.0m)

Accounts Payable

(652.0m)615.0m747.0m220.0m

Cash From Operating Activities

3.2b5.6b6.3b6.1b

Purchases of PP&E

(1.1b)(1.1b)(1.4b)(1.6b)

Cash From Investing Activities

(248.0m)(9.6b)(1.4b)(1.8b)

Short-term Borrowings

(1.8b)(1.0b)(26.0m)

Long-term Borrowings

14.9b(8.6b)(12.4b)(3.4b)

Dividends Paid

(1.5b)(1.8b)(2.0b)(2.3b)

Cash From Financing Activities

11.1b(5.3b)(10.4b)(4.3b)

Net Change in Cash

13.6b(9.2b)(5.6b)16.0m

Interest Paid

181.0m917.0m845.0m677.0m

Income Taxes Paid

620.0m570.0m740.0m930.0m

Abbott Ratios

USDFY, 2016

Revenue/Employee

278.0k

Debt/Equity

1.1 x

Debt/Assets

0.4 x

Financial Leverage

2.5 x

Abbott Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Manufacturing Sites

100 94 92

New Product Launches

25 25

Products

1.50 k1.50 k1.50 k

Research and Development Centers

12

Abbott Employee Rating

3.64083 votes
Culture & Values
3.5
Work/Life Balance
3.3
Senior Management
3.2
Salary & Benefits
3.7
Career Opportunities
3.3
Source